Nick Tate

Nick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.

His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.

His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.

Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.

Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.

Nick Tate's Articles

2 Buys for the Coronavirus-Fueled Telemedicine Trend

March 26, 2020 Bold Profits Daily, Investment Opportunities, Technology

- Telemedicine use is through the roof with the COVID-19 crisis — proving it’s both a promising health care alternative and profitable investment.

Coronavirus Set to Ignite This Sleeper Sector to New Highs

March 19, 2020 2020 Financial Crisis, Bold Profits Daily, Investment Opportunities

- Panic accelerates change. And the “coronavirus effect” has sent stocks on a roller-coaster ride, clearing the way for a new-world market. The biggest winners will be in this sleeper sector.

No. 1 Strategy for the Coronavirus Stock Market Rebound

February 27, 2020 2020 Financial Crisis, Bold Profits Daily, Trading Strategies

- Story Highlights: Why you shouldn’t panic over the market dips this week. A new coronavirus breakthrough shines a spotlight on a precision medicine ETF that’s on a tear. Paul Mampilly’s secret investing weapon to use during the “coronavirus effect” on the stock market. The coronavirus vaccine is here! We predicted it a few weeks back, […]

Invest in the New Cancer App Technology for 29% Every Year

February 20, 2020 Bold Profits Daily, Investment Opportunities, Technology

- A new phone app uses artificial intelligence to identify a rare form of cancer. It’s just the latest example of how AI is fueling the a HUGE precision medicine boom.

Smart Diabetes Patch Breakthrough for Huge Biotech Gains

February 13, 2020 Bold Profits Daily, Investment Opportunities, Technology

- A new “smart” patch delivers personalized, precise doses of medication to treat diabetes. This precision medicine advance is the latest to showcase the coming 985% boom in this America 2.0 mega trend.

3 Steps for Investing in the Coronavirus “Cure” by March

February 6, 2020 Bold Profits Daily, Investment Opportunities, Trading Strategies

- Coronavirus “cure” by March? Fast-track your portfolio by buying into precision medicine’s 985% boom now.

Coronavirus “Cure” Reveals 300%-Plus Gains Opportunity

January 30, 2020 Bold Profits Daily, Investment Opportunities

- The coronavirus “cure” is just one of several innovations in medicine that is remaking the U.S. health care system as we know it.

Top Stocks for America 2.0’s Telehealth Revolution

January 23, 2020 Bold Profits Daily, Investment Opportunities, Technology

- The next generation of telehealth tools is here — artificial intelligence, better remote sensors and genetics — remaking U.S. health care with a new, personal, “virtual” spin.